Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Epicore Bionetworks Inc. V.EBN

Industrials Pollution & Treatment Controls
"Epicore Bionetworks Inc develops, manufactures and markets biotechnology products based on natural microbes and enzymes for the aquaculture, agriculture and municipal industries."

TSXV:EBN - Post Discussion

Epicore Bionetworks Inc. > Annual results
View:
Post by rationalexuberance on Oct 08, 2016 10:41am

Annual results

Disappointed that the top-line growth was missing in Q4 but was happy to see the $800K c/f from operations and the US$3.4mil holding in cash (highest level of cash ever recorded)
Comment by ChaseYourDream on Oct 11, 2016 10:43pm
Agreed. In almost every metric, they have improved even as the Yr-to-Yr Revenue and Net saw a slight decline. $2,250k in quarterly revenue is still very close to the median results of the last 2+ years. Admirable consistency. Assets and Equity up (so too the retained earnings, but still outstanding for a company this small). The nearly 800k gain in CF Ops is the best yet. So they are leaning out ...more  
Epicore Bionetworks Inc.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities